Lonza and BioWa sign license agreements with Pfizer, Inc.
BioWa, Inc. and Lonza today announced that they have entered…
BioWa, Inc. and Lonza today announced that they have entered into research agreements with Pfizer Inc. allowing the use of the POTELLIGENT® CHOK1SV Cell Line in the research and development of multiple proprietary antibodies in Pfizer’s pipeline.